22 mar 2016 año - FDA requires a new boxed warning about the serious risks of misuse and abuse, which can lead to addiction, overdose and death. The FDA also requires several additional safety labeling changes across all prescription opioid products to include additional information on the risk of these medications.
Añadido al timeline:
fecha:
22 mar 2016 año
Ahora mismo
~ 9 years and 7 months ago